These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31743686)

  • 41. Inhibitors of F
    Denny WA
    Future Med Chem; 2021 May; 13(10):911-926. PubMed ID: 33845594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ATP synthase in slow- and fast-growing mycobacteria is active in ATP synthesis and blocked in ATP hydrolysis direction.
    Haagsma AC; Driessen NN; Hahn MM; Lill H; Bald D
    FEMS Microbiol Lett; 2010 Dec; 313(1):68-74. PubMed ID: 21039782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structures and interactions of proteins involved in the coupling function of the protonmotive F(o)F(1)-ATP synthase.
    Gaballo A; Zanotti F; Papa S
    Curr Protein Pept Sci; 2002 Aug; 3(4):451-60. PubMed ID: 12370007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variations of subunit {varepsilon} of the Mycobacterium tuberculosis F1Fo ATP synthase and a novel model for mechanism of action of the tuberculosis drug TMC207.
    Biukovic G; Basak S; Manimekalai MS; Rishikesan S; Roessle M; Dick T; Rao SP; Hunke C; Grüber G
    Antimicrob Agents Chemother; 2013 Jan; 57(1):168-76. PubMed ID: 23089752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.
    Tantry SJ; Markad SD; Shinde V; Bhat J; Balakrishnan G; Gupta AK; Ambady A; Raichurkar A; Kedari C; Sharma S; Mudugal NV; Narayan A; Naveen Kumar CN; Nanduri R; Bharath S; Reddy J; Panduga V; Prabhakar KR; Kandaswamy K; Saralaya R; Kaur P; Dinesh N; Guptha S; Rich K; Murray D; Plant H; Preston M; Ashton H; Plant D; Walsh J; Alcock P; Naylor K; Collier M; Whiteaker J; McLaughlin RE; Mallya M; Panda M; Rudrapatna S; Ramachandran V; Shandil R; Sambandamurthy VK; Mdluli K; Cooper CB; Rubin H; Yano T; Iyer P; Narayanan S; Kavanagh S; Mukherjee K; Balasubramanian V; Hosagrahara VP; Solapure S; Ravishankar S; Hameed P S
    J Med Chem; 2017 Feb; 60(4):1379-1399. PubMed ID: 28075132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linking structural features from mitochondrial and bacterial F-type ATP synthases to their distinct mechanisms of ATPase inhibition.
    Krah A
    Prog Biophys Mol Biol; 2015 Oct; 119(1):94-102. PubMed ID: 26140992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Therapeutic Role for the F
    Nesci S; Trombetti F; Algieri C; Pagliarani A
    SLAS Discov; 2019 Oct; 24(9):893-903. PubMed ID: 31266411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The structure of the catalytic domain of the ATP synthase from
    Zhang AT; Montgomery MG; Leslie AGW; Cook GM; Walker JE
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4206-4211. PubMed ID: 30683723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuation of the hypoxia-induced protein kinase Cdelta interaction with the 'd' subunit of F1Fo-ATP synthase in neonatal cardiac myocytes: implications for energy preservation and survival.
    Nguyen TT; Ogbi M; Yu Q; Johnson JA
    Biochem J; 2010 Jul; 429(2):335-45. PubMed ID: 20578995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Drugs Targeting the c-Ring of the F1FO-ATP Synthase.
    Pagliarani A; Nesci S; Ventrella V
    Mini Rev Med Chem; 2016; 16(10):815-24. PubMed ID: 26864551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cryo-EM structure of the Mycobacterium abscessus F
    Wong CF; Leow CY; Grüber G
    Biochem Biophys Res Commun; 2023 Sep; 671():140-145. PubMed ID: 37302287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V
    Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
    Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
    Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
    Segala E; Sougakoff W; Nevejans-Chauffour A; Jarlier V; Petrella S
    Antimicrob Agents Chemother; 2012 May; 56(5):2326-34. PubMed ID: 22354303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A tale of two inhibitors: diarylquinolines and squaramides.
    Chen J; Ekiert DC
    EMBO J; 2023 Aug; 42(15):e114912. PubMed ID: 37435707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a Novel Mycobacterial F-ATP Synthase Inhibitor and its Potency in Combination with Diarylquinolines.
    Hotra A; Ragunathan P; Ng PS; Seankongsuk P; Harikishore A; Sarathy JP; Saw WG; Lakshmanan U; Sae-Lao P; Kalia NP; Shin J; Kalyanasundaram R; Anbarasu S; Parthasarathy K; Pradeep CN; Makhija H; Dröge P; Poulsen A; Tan JHL; Pethe K; Dick T; Bates RW; Grüber G
    Angew Chem Int Ed Engl; 2020 Aug; 59(32):13295-13304. PubMed ID: 32337801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural products and other inhibitors of F
    Patel BA; D'Amico TL; Blagg BSJ
    Eur J Med Chem; 2020 Dec; 207():112779. PubMed ID: 32942072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dual-targeting succinate dehydrogenase and F
    Adolph C; Cheung CY; McNeil MB; Jowsey WJ; Williams ZC; Hards K; Harold LK; Aboelela A; Bujaroski RS; Buckley BJ; Tyndall JDA; Li Z; Langer JD; Preiss L; Meier T; Steyn AJC; Rhee KY; Berney M; Kelso MJ; Cook GM
    Cell Chem Biol; 2024 Apr; 31(4):683-698.e7. PubMed ID: 38151019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis.
    Koul A; Vranckx L; Dendouga N; Balemans W; Van den Wyngaert I; Vergauwen K; Göhlmann HWH; Willebrords R; Poncelet A; Guillemont J; Bald D; Andries K
    J Biol Chem; 2008 Sep; 283(37):25273-25280. PubMed ID: 18625705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue.
    Haagsma AC; Abdillahi-Ibrahim R; Wagner MJ; Krab K; Vergauwen K; Guillemont J; Andries K; Lill H; Koul A; Bald D
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1290-2. PubMed ID: 19075053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.